×
2023 Brochure Download
Register by 25 February to save up to £450

Designing and Optimizing PROTACs, Molecular Glues and Other Degrader Modalities

The ubiquitin-proteasome, lysosome and autophagy systems are all well-controlled, selective degradation pathways that are key cellular regulators in cancer, CNS and other diseases. A new generation of hetero bi-functional chimeras and small molecule monovalent degraders are being developed to hijack these systems for targeted protein degradation or stabilization. These molecules that include Proteolysis-targeting chimeras (PROTACs) and molecular glues are being used to seek out previously “undruggable” targets for therapeutic intervention. However, challenges do exist in terms of specificity, stability, biodistribution and penetration of these degrader molecules.

The 2nd Annual conference on Next-Generation Degraders & Glues brings together experts in the field to discuss these new therapeutic modalities, as well as issues underlying the use of targeted degradation as a new therapeutic approach.

View the agenda, register, or become a sponsor!

Register Early and Save
View Program
Sponsorship Opportunities
Register Now
Related Virtual Event: Designing Molecular Glues

Join the Community

CONTENT SUGGESTIONS

For program questions or suggestions,
please contact:
Tanuja Koppal, PhD
Senior Conference Director
tkoppal@healthtech.com

PARTNERING & SPONSORSHIP

For partnering and sponsorship info,
please contact:
Rod Eymael
Business Development Manager
T: (+1) 781-247-6286
reymael@healthtech.com

MEDIA ASSOCIATION

For media and association partnerships,
please contact:
Amberly Ortkiese
Marketing Manager
aortkiese@healthtech.com

Co-Located Event - Immuno-Oncology Summit Europe 2023
Health and Safety